This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Letters To The Editor

Chorea and Tardive Dyskinesia in a Patient Taking Risperidone

Nancy B. Carroll, Kathryn E. Boehm, and R. Todd Strickland

Published: July 1, 1999

Article Abstract

Letter to the Editor

Sir: The antipsychotic risperidone has been available in the United States since 1994. It has been widely used, as studies have shown that extrapyramidal symptoms are less common than with other antipsychotics, and that the incidence of side effects causing discontinuation is low. Risperidone was also shown to be effective and have minimal side effects in adolescents and children.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Related Articles

Volume: 60

Quick Links: Movement Disorders

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...